McGrath J M, Chestnut D H, Vincent R D, DeBruyn C S, Atkins B L, Poduska D J, Chatterjee P
Department of Anesthesia, University of Iowa College of Medicine, Iowa City.
Anesthesiology. 1994 May;80(5):1073-81; discussion 28A. doi: 10.1097/00000542-199405000-00016.
Historically, ephedrine has been the vasopressor of choice for treatment of most cases of hypotension in obstetric patients. However, the choice of vasopressor in the parturient receiving a beta-adrenergic agent for tocolysis has not been evaluated extensively. The current study evaluated whether ephedrine or phenylephrine better restores uterine blood flow and fetal oxygenation during ritodrine infusion and epidural anesthesia-induced hypotension in gravid ewes.
Fourteen chronically instrumented gravid ewes between 0.8 and 0.9 timed gestational age were used. On separate days, each animal underwent the experimental protocol with one of three agents: ephedrine, phenylephrine, and normal saline-control. The experimental protocol was as follows: (1) at time zero, intravenous infusion of ritodrine was begun; (2) at 120 min, 2% lidocaine was given epidurally to achieve a sensory level of at least T6; and (3) at 135 min, an intravenous bolus of either ephedrine, phenylephrine, or normal saline-control was given, followed by a continuous intravenous infusion of the same agent for 30 min. In the ephedrine and phenylephrine experiments, the rate of infusion was adjusted to maintain maternal mean arterial pressure close to baseline.
Ritodrine infusion alone significantly increased maternal heart rate and cardiac output in all three groups. Epidural anesthesia during ritodrine infusion significantly decreased maternal mean arterial pressure, heart rate, cardiac output, uterine blood flow, and fetal arterial oxygen tension for each of the three groups. Both ephedrine and phenylephrine restored maternal mean arterial pressure to baseline, as designed. Ephedrine significantly increased uterine blood flow and fetal arterial oxygen tension when compared with normal saline--control, but phenylephrine did not. Phenylephrine significantly increased uterine vascular resistance when compared with normal saline--control, but ephedrine did not.
Although ephedrine and phenylephrine provided similar restoration of maternal mean arterial pressure, ephedrine was superior to phenylephrine in restoring uterine blood flow during ritodrine infusion and epidural anesthesia-induced hypotension in gravid ewes. Also, ephedrine, but not phenylephrine, significantly improved fetal oxygenation, when compared to normal saline--control.
从历史上看,麻黄碱一直是治疗大多数产科患者低血压的首选血管升压药。然而,对于接受β-肾上腺素能药物进行保胎治疗的产妇,血管升压药的选择尚未得到广泛评估。本研究评估了在妊娠母羊静脉输注利托君和硬膜外麻醉诱导低血压期间,麻黄碱或去氧肾上腺素能否更好地恢复子宫血流和胎儿氧合。
使用14只妊娠0.8至0.9孕周的慢性植入监测装置的妊娠母羊。在不同的日子里,每只动物接受三种药物之一的实验方案:麻黄碱、去氧肾上腺素和生理盐水对照。实验方案如下:(1)在时间为零时,开始静脉输注利托君;(2)在120分钟时,硬膜外给予2%利多卡因以达到至少T6的感觉平面;(3)在135分钟时,静脉推注麻黄碱、去氧肾上腺素或生理盐水对照,随后持续静脉输注相同药物30分钟。在麻黄碱和去氧肾上腺素实验中,调整输注速率以维持产妇平均动脉压接近基线。
单独输注利托君在所有三组中均显著增加产妇心率和心输出量。在输注利托君期间进行硬膜外麻醉,三组中的每一组产妇平均动脉压、心率、心输出量、子宫血流量和胎儿动脉氧分压均显著降低。如预期的那样,麻黄碱和去氧肾上腺素均将产妇平均动脉压恢复到基线。与生理盐水对照相比,麻黄碱显著增加子宫血流量和胎儿动脉氧分压,但去氧肾上腺素没有。与生理盐水对照相比,去氧肾上腺素显著增加子宫血管阻力,但麻黄碱没有。
虽然麻黄碱和去氧肾上腺素在恢复产妇平均动脉压方面相似,但在妊娠母羊静脉输注利托君和硬膜外麻醉诱导低血压期间,麻黄碱在恢复子宫血流方面优于去氧肾上腺素。此外,与生理盐水对照相比,麻黄碱能显著改善胎儿氧合,而去氧肾上腺素则不能。